Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2011

01-09-2011 | Article

Identification of immunogenic regions within the alternative reading frame protein of hepatitis C virus (genotype 3)

Authors: H. Qureshi, R. Qazi, S. Hamid, S. A. Qureshi

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2011

Login to get access

Abstract

Hepatitis C virus (HCV) encodes ten classic proteins as well as a newly discovered alternative reading frame protein (ARFP) whose synthesis originates from the core region by a +1 frameshift. ARFP is produced by all HCV genotypes, but its function remains unknown. Although the immunogenicity of genotype 1- and 2-derived ARFP in infected hosts has been reported, no information is available for genotype 3-encoded ARFP. HCV genotype 3 core/ARFP region was PCR amplified, cloned, and sequenced. Recombinant ARFP and peptides were employed in ELISAs with patient serum samples. The effect of peptides on peripheral blood mononucleocytes (PBMCs) was also studied. DNA cloning and sequencing of HCV genotype 3 strain (PKHCV3) revealed it to encode 160 aa ARFP, which harbors a C-terminal extension of 36 aa. Serum from 74 of 88 patients (84%) contained rARFP-reactive antibodies. Peptide ELISAs showed that all regions of rARFP were immunogenic, with peptide F7 (DSLSPRRAGAKAGPGLSPGT) being the most immunodominant. When incubated with PBMCs from HCV-infected individuals, F7 stimulated the production of TNFα and IL10. PKHCV3-derived ARFP encodes a 160 aa protein and antibodies against its entire length are found in 84% of all genotype 3-infected subjects. Peptide ELISAs revealed F7 to be highly immunogenic and capable of eliciting impressive T-cell responses.
Literature
1.
go back to reference Qureshi SA, Qureshi H, Hameed A (2009) Hepatitis C therapy—the future looks bright. Eur J Clin Microbiol Infect Dis 28(12):1409–1413PubMedCrossRef Qureshi SA, Qureshi H, Hameed A (2009) Hepatitis C therapy—the future looks bright. Eur J Clin Microbiol Infect Dis 28(12):1409–1413PubMedCrossRef
2.
go back to reference Qureshi SA (2007) Hepatitis C virus—biology, host evasion strategies, and promising new therapies on the horizon. Med Res Rev 27(3):353–373PubMedCrossRef Qureshi SA (2007) Hepatitis C virus—biology, host evasion strategies, and promising new therapies on the horizon. Med Res Rev 27(3):353–373PubMedCrossRef
3.
go back to reference Branch AD, Stump DD, Gutierrez JA, Eng F, Walewski JL (2005) The hepatitis C virus alternate reading frame (ARF) and its family of novel products: the alternate reading frame protein/F-protein, the double-frameshift protein, and others. Semin Liver Dis 25(1):105–117PubMedCrossRef Branch AD, Stump DD, Gutierrez JA, Eng F, Walewski JL (2005) The hepatitis C virus alternate reading frame (ARF) and its family of novel products: the alternate reading frame protein/F-protein, the double-frameshift protein, and others. Semin Liver Dis 25(1):105–117PubMedCrossRef
4.
go back to reference Vassilaki N, Mavromara P (2009) The HCV ARFP/F/core+1 protein: production and functional analysis of an unconventional viral product. IUBMB Life 61(7):739–752PubMedCrossRef Vassilaki N, Mavromara P (2009) The HCV ARFP/F/core+1 protein: production and functional analysis of an unconventional viral product. IUBMB Life 61(7):739–752PubMedCrossRef
5.
go back to reference Vassilaki N, Mavromara P (2003) Two alternative translation mechanisms are responsible for the expression of the HCV ARFP/F/core+1 coding open reading frame. J Biol Chem 278(42):40503–40513PubMedCrossRef Vassilaki N, Mavromara P (2003) Two alternative translation mechanisms are responsible for the expression of the HCV ARFP/F/core+1 coding open reading frame. J Biol Chem 278(42):40503–40513PubMedCrossRef
6.
go back to reference Baril M, Brakier-Gingras L (2005) Translation of the F protein of hepatitis C virus is initiated at a non-AUG codon in a +1 reading frame relative to the polyprotein. Nucleic Acids Res 33(5):1474–1486PubMedCrossRef Baril M, Brakier-Gingras L (2005) Translation of the F protein of hepatitis C virus is initiated at a non-AUG codon in a +1 reading frame relative to the polyprotein. Nucleic Acids Res 33(5):1474–1486PubMedCrossRef
7.
go back to reference Boulant S, Becchi M, Penin F, Lavergne JP (2003) Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b. J Biol Chem 278(46):45785–45792PubMedCrossRef Boulant S, Becchi M, Penin F, Lavergne JP (2003) Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b. J Biol Chem 278(46):45785–45792PubMedCrossRef
8.
go back to reference Ratinier M, Boulant S, Combet C, Targett-Adams P, McLauchlan J, Lavergne JP (2008) Transcriptional slippage prompts recoding in alternate reading frames in the hepatitis C virus (HCV) core sequence from strain HCV-1. J Gen Virol 89(Pt 7):1569–1578PubMedCrossRef Ratinier M, Boulant S, Combet C, Targett-Adams P, McLauchlan J, Lavergne JP (2008) Transcriptional slippage prompts recoding in alternate reading frames in the hepatitis C virus (HCV) core sequence from strain HCV-1. J Gen Virol 89(Pt 7):1569–1578PubMedCrossRef
9.
go back to reference Yuksek K, Chen WL, Chien D, Ou JH (2009) Ubiquitin-independent degradation of hepatitis C virus F protein. J Virol 83(2):612–621PubMedCrossRef Yuksek K, Chen WL, Chien D, Ou JH (2009) Ubiquitin-independent degradation of hepatitis C virus F protein. J Virol 83(2):612–621PubMedCrossRef
10.
go back to reference Boumlic A, Nominé Y, Charbonnier S, Dalagiorgou G, Vassilaki N, Kieffer B, Travé G, Mavromara P, Orfanoudakis G (2010) Prevalence of intrinsic disorder in the hepatitis C virus ARFP/Core+1/S protein. FEBS J 277(3):774–789PubMedCrossRef Boumlic A, Nominé Y, Charbonnier S, Dalagiorgou G, Vassilaki N, Kieffer B, Travé G, Mavromara P, Orfanoudakis G (2010) Prevalence of intrinsic disorder in the hepatitis C virus ARFP/Core+1/S protein. FEBS J 277(3):774–789PubMedCrossRef
11.
go back to reference Vassilaki N, Friebe P, Meuleman P, Kallis S, Kaul A, Paranhos-Baccalà G, Leroux-Roels G, Mavromara P, Bartenschlager R (2008) Role of the hepatitis C virus core+1 open reading frame and core cis-acting RNA elements in viral RNA translation and replication. J Virol 82(23):11503–11515PubMedCrossRef Vassilaki N, Friebe P, Meuleman P, Kallis S, Kaul A, Paranhos-Baccalà G, Leroux-Roels G, Mavromara P, Bartenschlager R (2008) Role of the hepatitis C virus core+1 open reading frame and core cis-acting RNA elements in viral RNA translation and replication. J Virol 82(23):11503–11515PubMedCrossRef
12.
go back to reference Ma HC, Lin TW, Li H, Iguchi-Ariga SM, Ariga H, Chuang YL, Ou JH, Lo SY (2008) Hepatitis C virus ARFP/F protein interacts with cellular MM-1 protein and enhances the gene trans-activation activity of c-Myc. J Biomed Sci 15(4):417–425PubMedCrossRef Ma HC, Lin TW, Li H, Iguchi-Ariga SM, Ariga H, Chuang YL, Ou JH, Lo SY (2008) Hepatitis C virus ARFP/F protein interacts with cellular MM-1 protein and enhances the gene trans-activation activity of c-Myc. J Biomed Sci 15(4):417–425PubMedCrossRef
13.
go back to reference Basu A, Steele R, Ray R, Ray RB (2004) Functional properties of a 16 kDa protein translated from an alternative open reading frame of the core-encoding genomic region of hepatitis C virus. J Gen Virol 85(Pt 8):2299–2306PubMedCrossRef Basu A, Steele R, Ray R, Ray RB (2004) Functional properties of a 16 kDa protein translated from an alternative open reading frame of the core-encoding genomic region of hepatitis C virus. J Gen Virol 85(Pt 8):2299–2306PubMedCrossRef
14.
go back to reference Dou J, Liu P, Wang J, Zhang X (2006) Effect of hepatitis C virus core shadow protein expressed in human hepatoma cell line on human gene expression profiles. J Gastroenterol Hepatol 21(12):1794–1800PubMedCrossRef Dou J, Liu P, Wang J, Zhang X (2006) Effect of hepatitis C virus core shadow protein expressed in human hepatoma cell line on human gene expression profiles. J Gastroenterol Hepatol 21(12):1794–1800PubMedCrossRef
15.
go back to reference Huang YP, Cheng J, Zhang SL, Wang L, Guo J, Liu Y, Yang Y, Zhang LY, Bai GQ, Gao XS, Ji D, Lin SM, Shao Q (2005) Screening of hepatocyte proteins binding to F protein of hepatitis C virus by yeast two-hybrid system. World J Gastroenterol 11(36):5659–5665PubMed Huang YP, Cheng J, Zhang SL, Wang L, Guo J, Liu Y, Yang Y, Zhang LY, Bai GQ, Gao XS, Ji D, Lin SM, Shao Q (2005) Screening of hepatocyte proteins binding to F protein of hepatitis C virus by yeast two-hybrid system. World J Gastroenterol 11(36):5659–5665PubMed
16.
go back to reference Wolf M, Dimitrova M, Baumert TF, Schuster C (2008) The major form of hepatitis C virus alternate reading frame protein is suppressed by core protein expression. Nucleic Acids Res 36(9):3054–3064PubMedCrossRef Wolf M, Dimitrova M, Baumert TF, Schuster C (2008) The major form of hepatitis C virus alternate reading frame protein is suppressed by core protein expression. Nucleic Acids Res 36(9):3054–3064PubMedCrossRef
17.
go back to reference Shao SW, Wu WB, Bian ZQ, Yu JG, Zhao P, Zhao LJ, Zhu SY, Qi ZT (2009) Hepatitis C virus F protein inhibits cell apoptosis by activation of intracellular NF-kappaB pathway. Hepatol Res 39(3):282–289PubMedCrossRef Shao SW, Wu WB, Bian ZQ, Yu JG, Zhao P, Zhao LJ, Zhu SY, Qi ZT (2009) Hepatitis C virus F protein inhibits cell apoptosis by activation of intracellular NF-kappaB pathway. Hepatol Res 39(3):282–289PubMedCrossRef
18.
go back to reference Bain C, Parroche P, Lavergne JP, Duverger B, Vieux C, Dubois V, Komurian-Pradel F, Trépo C, Gebuhrer L, Paranhos-Baccalà G, Penin F, Inchauspé G (2004) Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection. J Virol 78(19):10460–10469PubMedCrossRef Bain C, Parroche P, Lavergne JP, Duverger B, Vieux C, Dubois V, Komurian-Pradel F, Trépo C, Gebuhrer L, Paranhos-Baccalà G, Penin F, Inchauspé G (2004) Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection. J Virol 78(19):10460–10469PubMedCrossRef
19.
go back to reference Gao DY, Zhang XX, Hou G, Jin GD, Deng Q, Kong XF, Zhang DH, Ling Y, Yu DM, Gong QM, Zhan Q, Yao BL, Lu ZM (2008) Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin. J Clin Microbiol 46(11):3746–3751PubMedCrossRef Gao DY, Zhang XX, Hou G, Jin GD, Deng Q, Kong XF, Zhang DH, Ling Y, Yu DM, Gong QM, Zhan Q, Yao BL, Lu ZM (2008) Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin. J Clin Microbiol 46(11):3746–3751PubMedCrossRef
20.
go back to reference Chuang WC, Allain JP (2008) Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections. J Gen Virol 89(Pt 8):1890–1900PubMedCrossRef Chuang WC, Allain JP (2008) Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections. J Gen Virol 89(Pt 8):1890–1900PubMedCrossRef
21.
go back to reference Xu Z, Choi J, Yen TS, Lu W, Strohecker A, Govindarajan S, Chien D, Selby MJ, Ou J (2001) Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J 20(14):3840–3848PubMedCrossRef Xu Z, Choi J, Yen TS, Lu W, Strohecker A, Govindarajan S, Chien D, Selby MJ, Ou J (2001) Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J 20(14):3840–3848PubMedCrossRef
22.
go back to reference Varaklioti A, Vassilaki N, Georgopoulou U, Mavromara P (2002) Alternate translation occurs within the core coding region of the hepatitis C viral genome. J Biol Chem 277(20):17713–17721PubMedCrossRef Varaklioti A, Vassilaki N, Georgopoulou U, Mavromara P (2002) Alternate translation occurs within the core coding region of the hepatitis C viral genome. J Biol Chem 277(20):17713–17721PubMedCrossRef
23.
go back to reference Walewski JL, Keller TR, Stump DD, Branch AD (2001) Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 7(5):710–721PubMedCrossRef Walewski JL, Keller TR, Stump DD, Branch AD (2001) Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 7(5):710–721PubMedCrossRef
24.
go back to reference Cohen M, Bachmatov L, Ben-Ari Z, Rotman Y, Tur-Kaspa R, Zemel R (2007) Development of specific antibodies to an ARF protein in treated patients with chronic HCV infection. Dig Dis Sci 52(9):2427–2432PubMedCrossRef Cohen M, Bachmatov L, Ben-Ari Z, Rotman Y, Tur-Kaspa R, Zemel R (2007) Development of specific antibodies to an ARF protein in treated patients with chronic HCV infection. Dig Dis Sci 52(9):2427–2432PubMedCrossRef
25.
go back to reference Komurian-Pradel F, Rajoharison A, Berland JL, Khouri V, Perret M, Van Roosmalen M, Pol S, Negro F, Paranhos-Baccalà G (2004) Antigenic relevance of F protein in chronic hepatitis C virus infection. Hepatology 40(4):900–909PubMed Komurian-Pradel F, Rajoharison A, Berland JL, Khouri V, Perret M, Van Roosmalen M, Pol S, Negro F, Paranhos-Baccalà G (2004) Antigenic relevance of F protein in chronic hepatitis C virus infection. Hepatology 40(4):900–909PubMed
Metadata
Title
Identification of immunogenic regions within the alternative reading frame protein of hepatitis C virus (genotype 3)
Authors
H. Qureshi
R. Qazi
S. Hamid
S. A. Qureshi
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2011
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1194-1

Other articles of this Issue 9/2011

European Journal of Clinical Microbiology & Infectious Diseases 9/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.